J&J Sees Rx Synergies In Guidant Deal; Big Buy Does Not Rule Out More Deals

J&J's acquisition of Guidant will open up new areas of opportunity for collaboration between the pharmaceutical, device and diagnostic operations of the company, CEO William Weldon declared during a Dec. 16 analysts conference call